Rivastigmine

TERMINATED · PHASE3 · Cognitive Symptoms

The Principal Investigator left the clinic and there was no one who could take over this study.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.